IVD & Diagnostics — Diagnostics expertise where evidence and access intersect.

Product Assessment Understand assay, platform and intended use. Performance Evidence Review analytical and clinical performance context. Technical Documentation Organize regulatory and manufacturer information. Market Access Connect registration with commercial planning.

Diagnostic Market Access Begins with Intended Use and Evidence An IVD product should be evaluated within the context of what it detects, who it is intended for, how it performs, where it is used and what evidence supports its claims. IVD & Diagnostics Industry

Build the Regulatory Strategy Around the Diagnostic Claim

IVD and diagnostic products sit at the intersection of medical technology, laboratory practice, evidence generation and regulatory oversight. The pathway therefore requires more than identifying the product name or manufacturer.

Ziva DRA helps clients review intended use, technical characteristics, performance information, existing approvals and manufacturer documentation before structuring the Bangladesh regulatory workstream.

For companies evaluating market entry, the regulatory program can also be connected with market research, competitor analysis, laboratory-sector intelligence and broader business-compliance support.

Intended Use & Product Review Clarify the diagnostic purpose, user, specimen, technology and target application. Performance Evidence Review Assess available analytical, clinical or performance information relevant to the product. Documentation Readiness Organize technical, labeling, quality and manufacturer documentation for the workstream. Integrated Market Entry Connect registration with diagnostics-market research and commercial planning.

IVD Market Access

Six Dimensions That Can Shape an IVD Regulatory Program

The precise requirements depend on the diagnostic, technology, claims, evidence and intended market role.

Intended Use & Diagnostic Claim

Understand what the test detects, its intended population, specimen type, setting and claimed diagnostic function.

Technology & Methodology

Review the underlying assay, platform, instrumentation or analytical methodology relevant to the product.

Performance Evidence

Evaluate available analytical, clinical and other performance information supporting product claims.

Technical Documentation

Organize product, quality, labeling and supporting manufacturer documentation for regulatory review.

Local Market Structure

Address local representation, commercial structure and other market-entry dependencies where relevant.

Lifecycle Compliance

Consider registration maintenance, product changes and continuing compliance after market entry.

Diagnostic Portfolio Coverage

Support Across Diverse IVD & Diagnostic Categories

Different technologies and diagnostic purposes may require different evidence and regulatory strategies.

Clinical Chemistry

Reagents, assays and diagnostic systems supporting chemical and biochemical testing.

Molecular Diagnostics

Nucleic-acid, molecular and related diagnostic technologies.

Hematology & Immunology

Diagnostic systems supporting blood, immune and related laboratory testing.

Point-of-Care Diagnostics

Rapid and near-patient diagnostic technologies used outside traditional central laboratories.

IVD Market-Entry Journey

From Diagnostic Assessment to Market Participation

A structured sequence helps evidence, documentation and regulatory execution remain aligned.

Assess Review intended use, technology and current approvals. Evaluate Review performance evidence and documentation gaps. Prepare Organize technical and manufacturer documentation. Execute Progress the applicable registration workstream. Maintain & Grow Support ongoing compliance and market development.

Relevant Ziva DRA Services

Build the IVD Program Around the Workstreams You Need

Use a focused registration service or combine regulatory, evidence and market-intelligence capabilities.

IVD Registration

Regulatory assessment, documentation preparation and registration support for diagnostic products.

Explore IVD Registration

Local Authorized Representative

Local regulatory support for international diagnostic and IVD manufacturers.

Explore Local Representation

Clinical Research

Evidence-generation and research support where additional diagnostic evidence is needed.

Explore Clinical Research

Market Research

Research laboratory customers, healthcare segments, commercial channels and market-entry conditions.

Explore Market Research

Competitor Analysis

Understand competing diagnostic brands, platforms, products and market positioning.

Explore Competitor Analysis

Market Entry Reports

Combine regulatory, market and competitive intelligence into a decision-oriented report.

Explore Market Entry Reports

Global Market Access

Support multi-market expansion and global regulatory planning for diagnostic portfolios.

Explore Global Market Access

Regulatory Updates

Track regulatory changes affecting diagnostic registration and market access.

Explore Regulatory Updates

Business Compliance

Connect product entry with company, trade and operational compliance requirements.

Explore Business Compliance

Diagnostic Market Intelligence

Align Regulatory Feasibility with Diagnostic-Market Reality

Diagnostic market entry should consider both the technical-regulatory pathway and the laboratory ecosystem.

Regulatory & Evidence Questions

Define the technical and evidence pathway before execution.

What is the intended diagnostic use? What specimen and methodology are involved? What performance evidence is available? What technical documentation gaps exist? What local representation structure is appropriate? What lifecycle obligations may follow registration?

Commercial & Market Questions

Understand the diagnostic ecosystem surrounding the product.

Which laboratories or healthcare segments are relevant? Which competing platforms are present? How is testing currently performed? Which distribution channels may matter? What adoption barriers could affect entry? Which products should be prioritized first?

IVD Strategy

Turn Diagnostic Evidence into a Market-Access Capability

The strongest IVD programs connect technical performance, regulatory readiness and commercial strategy from the beginning.

Clearer Pathway

Define regulatory and evidence requirements earlier.

Evidence Visibility

Understand whether current performance information supports the project.

Integrated Execution

Connect evidence, registration and commercial workstreams.

Portfolio Scalability

Create a stronger model for multiple assays and diagnostic products.

Related Industries

Explore Connected Medical & Laboratory Sectors

Medical Devices

Regulatory and market-access support across the broader medical technology sector.

Explore Medical Devices →

Laboratory Equipment

Market-entry and regulatory intelligence for laboratory instruments and testing technologies.

Explore Laboratory Equipment →

Biotechnology

Regulatory, clinical and strategic support for biotechnology and emerging diagnostic technologies.

Explore Biotechnology →

Frequently Asked Questions

IVD & Diagnostic Market-Entry Questions

Can Ziva DRA support international IVD manufacturers?

Yes. International manufacturers can engage Ziva DRA for regulatory assessment, IVD registration, local representation, market intelligence and related market-entry support.

Does every IVD product follow the same regulatory pathway?

No. The pathway can vary according to intended use, technology, product characteristics, evidence and the applicable regulatory framework.

Can you review existing performance evidence before registration?

Yes. Available analytical, clinical or other performance information can be reviewed as part of the regulatory-readiness assessment.

Can technical documentation be reviewed before submission?

Yes. A documentation-readiness review can identify gaps before the registration workstream progresses.

Can market research be completed before we invest in registration?

Yes. Market Research, Competitor Analysis and Market Entry Reports can help evaluate commercial conditions before a larger regulatory commitment.

Can several diagnostic products be managed under one project?

Yes. A portfolio can be reviewed collectively and organized into product-specific regulatory workstreams where appropriate.

Planning to Introduce IVD or Diagnostic Products into Bangladesh?

Share your manufacturer profile, diagnostic portfolio, intended uses, existing approvals, performance evidence and market-entry objectives with Ziva DRA. We can help structure the regulatory, evidence and commercial workstreams required for your diagnostic program.

Start an IVD & Diagnostics Project